Australia markets closed

Hutchison China MediTech Limited (HCM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
31.02-2.13 (-6.43%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 54.28B
Enterprise value 34.33B
Trailing P/E N/A
Forward P/E 1-39.27
PEG ratio (5-yr expected) 10.92
Price/sales (ttm)20.46
Price/book (mrq)12.46
Enterprise value/revenue 320.68
Enterprise value/EBITDA 6-29.46

Trading information

Stock price history

Beta (5Y monthly) 0.95
52-week change 355.10%
S&P500 52-week change 315.36%
52-week high 334.08
52-week low 314.74
50-day moving average 328.75
200-day moving average 323.81

Share statistics

Avg vol (3-month) 3309.47k
Avg vol (10-day) 3361.52k
Shares outstanding 566.5M
Float 62.12M
% held by insiders 16.60%
% held by institutions 130.65%
Shares short (30 Jul 2020) 41.01M
Short ratio (30 Jul 2020) 43.92
Short % of float (30 Jul 2020) 4N/A
Short % of shares outstanding (30 Jul 2020) 40.71%
Shares short (prior month 29 Jun 2020) 41.12M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:1
Last split date 329 May 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)29 Jun 2020


Profit margin -52.68%
Operating margin (ttm)-72.83%

Management effectiveness

Return on assets (ttm)-18.68%
Return on equity (ttm)-29.31%

Income statement

Revenue (ttm)209.46M
Revenue per share (ttm)1.55
Quarterly revenue growth (yoy)6.70%
Gross profit (ttm)-93.45M
EBITDA -147.08M
Net income avi to common (ttm)-110.35M
Diluted EPS (ttm)-0.82
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)281.01M
Total cash per share (mrq)2.05
Total debt (mrq)33.29M
Total debt/equity (mrq)9.07
Current ratio (mrq)3.14
Book value per share (mrq)2.49

Cash flow statement

Operating cash flow (ttm)-79.24M
Levered free cash flow (ttm)-97.72M